North Wales, PA, United States of America

Donald E Griswold


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Donald E. Griswold

Introduction: Donald E. Griswold, based in North Wales, Pennsylvania, is a notable inventor recognized for his impactful work in the field of medicine. His pioneering research led to the development of a valuable patent that holds promise for treating various inflammatory diseases.

Latest Patents: Donald E. Griswold holds a significant patent titled "CXCL13 antagonists and their use for the treatment of inflammatory diseases." This patent outlines methods for treating disorders associated with CXCL13 activity by utilizing CXCL13 antagonists and, optionally, TNFα antagonists. The described methods involve various forms such as antibodies, polypeptides, polynucleotides, siRNA, shRNA, ribozymes, and DNAzymes. The inflammatory disorders targeted by this invention include pulmonary diseases like asthma, emphysema, and Chronic Obstructive Pulmonary Disease (COPD), as well as systemic lupus erythematosus.

Career Highlights: Donald currently works at Centocor, Inc., an organization dedicated to innovative solutions in healthcare. His role at the company has allowed him to focus on developing treatments that address complex inflammatory disorders.

Collaborations: Throughout his career, Donald has collaborated with esteemed colleagues such as Peter Bugelski and Anuk Das. These collaborations have played a crucial role in advancing his research and patent development, driving impactful progress in healthcare.

Conclusion: Donald E. Griswold's contributions to the field of medicine through his patent on CXCL13 antagonists exemplify the kind of innovation that is vital for addressing prevalent health issues. His work not only showcases the spirit of invention but also highlights the importance of collaboration in achieving significant breakthroughs in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…